GSK Set for $500 Million Payment From mRNA Lawsuit Settlement

Biotech Law | Intellectual Property | Business Litigation Introduction: A Settlement Years in the Making In a significant resolution to one of the most closely watched biotechnology IP battles, CureVac NV has reached a settlement with Pfizer Inc. and BioNTech SE over allegations of patent infringement related to mRNA vaccine technology.

CVS Caremark Ordered to Pay $95 Million

Whistleblower Claims | False Claims Act | Medicare Oversight A federal judge has ordered CVS Health’s pharmacy benefit manager unit, Caremark, to pay $95 million following a bench trial in a whistleblower case alleging systematic overcharging of Medicare. This ruling, delivered by Chief Judge Mitchell Goldberg, reinforces the government's rigorous stance